News

Understanding Options Activity for Viking Therapeutics (VKTX)

Understanding Options Activity for Viking Therapeutics (VKTX)

Insights into the Options Trading of Viking Therapeutics

Investors with substantial capital are showcasing a strong bullish outlook on Viking Therapeutics.

By examining the options history for Viking Therapeutics (NASDAQ: VKTX), we’ve identified 13 trades that give us insight into market sentiment.

Analyzing these trades reveals that around 69% of the investors adopted a bullish stance, while 30% favored bearish positions.

Out of the total trades, there are 6 puts valued at approximately $453,915 and 7 calls amounting to $500,554.

Forecasted Price Range for VKTX

Recent trading activities suggest that key investors are targeting a price range between $20.00 and $100.00 for Viking Therapeutics over the past three months.

Examining Volume and Open Interest Trends

Monitoring volume and open interest is crucial when engaging in options trading. This information helps assess the liquidity and demand for Viking Therapeutics's options at specific strike prices. In the last 30 days, we can analyze the volume and open interest for all trades related to Viking Therapeutics, particularly within the targeted strike price range of $20.00 to $100.00.

Overview of Call and Put Volume for the Past 30 Days

In this period, we've observed active engagement in options trading for Viking Therapeutics, confirming sustained interest amongst investors.

Significant Options Activity

Detailed below is a breakdown of notable options trades for Viking Therapeutics:

Symbol: VKTX
Put/Call: Call
Trade Type: Sweep
Sentiment: Bullish
Expiration Date: 01/16/26
Ask Price: $7.20
Bid Price: $7.00
Trade Price: $7.20
Strike Price: $35.00
Total Trade Value: $160.5K
Open Interest: 1.3K
Volume: 297

Symbol: VKTX
Put/Call: Put
Trade Type: Sweep
Sentiment: Bullish
Expiration Date: 03/21/25
Ask Price: $1.43
Bid Price: $1.42
Trade Price: $1.42
Strike Price: $25.00
Total Trade Value: $142.1K
Open Interest: 216
Volume: 1.0K

Symbol: VKTX
Put/Call: Put
Trade Type: Sweep
Sentiment: Bullish
Expiration Date: 03/21/25
Ask Price: $1.85
Bid Price: $1.43
Trade Price: $1.44
Strike Price: $25.00
Total Trade Value: $141.6K
Open Interest: 216
Volume: 2.6K

Symbol: VKTX
Put/Call: Call
Trade Type: Trade
Sentiment: Bullish
Expiration Date: 03/21/25
Ask Price: $1.05
Bid Price: $0.99
Trade Price: $1.05
Strike Price: $35.00
Total Trade Value: $105.0K
Open Interest: 6.0K
Volume: 199

Symbol: VKTX
Put/Call: Put
Trade Type: Sweep
Sentiment: Bearish
Expiration Date: 03/21/25
Ask Price: $1.85
Bid Price: $1.46
Trade Price: $1.46
Strike Price: $25.00
Total Trade Value: $57.1K
Open Interest: 216
Volume: 2.6K

About Viking Therapeutics

Viking Therapeutics Inc is a forward-thinking healthcare service provider specializing in biopharmaceutical development. The company focuses particularly on metabolic and endocrine disorders, boasting a robust clinical pipeline including VK2809, VK5211, and VK0214. The first two are selective agonists of the thyroid hormone receptor beta, while VK5211 is a non-steroidal selective androgen receptor modulator.

Current Market Position of Viking Therapeutics

  • With an active trading volume of 4,281,250, VKTX has seen a decline of 3.94%, currently priced at $28.05.
  • The current Relative Strength Index (RSI) suggests the stock may be trending towards an oversold condition.
  • The upcoming earnings report is anticipated within the next 57 days.

Analyst Recommendations for Viking Therapeutics

In the previous month, 5 analysts have analyzed this stock, establishing an average price target of $81.20. Notably:

  • An analyst from Maxim Group has reaffirmed a Buy rating for Viking Therapeutics, setting a price target of $70.
  • Citigroup downgraded its action to Neutral, altering the price target to $38.
  • Raymond James maintained a Strong Buy rating, proposing a price target of $125.
  • Scotiabank adjusted its rating to Sector Outperform, now targeting $102.
  • Piper Sandler keeps an Overweight stance with a price target of $71.

Engaging in options trading involves both elevated risks and potential rewards. Prudent traders navigate these challenges by continually enhancing their knowledge, adapting strategies, and monitoring various market indicators actively. You can stay updated on the latest Viking Therapeutics options trading dynamics through real-time alerts.

Frequently Asked Questions

What is Viking Therapeutics?

Viking Therapeutics Inc is a healthcare company focused on developing treatments for metabolic and endocrine disorders.

What does the recent options activity indicate?

The options activity suggests a bullish sentiment among significant investors for Viking Therapeutics.

What is the current stock price of VKTX?

As of the latest update, VKTX is priced at $28.05, reflecting a decrease of 3.94%.

What is the forecasted price range for VKTX?

Key investors are targeting a price range of $20.00 to $100.00 for VKTX based on recent trading.

What are analysts saying about VKTX?

Analysts have varying predictions, with average price targets ranging from $38 to $125, indicating a mix of opinions on its future performance.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Decoding Real Estate Value: A Market Insider's Take

Updated Category News Views 189

Riding the Waves of Real Estate Pricing Homeowners dipping their toes into the real estate market know that setting the right price ain't a walk in the park. Luckily, Matt Nuzie, Shelton's real estate pro, has peeled back the layers on comparative market analyses (CMA) in a HelloNation piece. This isn't just about tossing a number out there—it's about understanding the...

Continue Reading
Bahrain's USD 3.89 Billion Investment Surge in 2026

Updated Category News Views 125

Bahrain's Bold Moves to Woo Global Investment Bahrain's never been one to tiptoe around, huh? With a whopping USD 3.89 billion on the line, the Kingdom's flashing its neon sign to investors: "Open for Business!" These Golden License projects aren't just a few shiny new ventures — they're bridging aviation logistics, real estate, and the tech sector. Talk about ambition....

Continue Reading
Yangtze River Culture Festival Spotlights Integration, Tradition

Updated Category News Views 262

A Celebration of Culture and Integration Here's an event that flips the script on the typical festival circuit: the 2026 Yangtze River Culture Festival. It's as much about heritage as it is about economics, dovetailing culture with tourism in a way that makes wallets a little fatter and souls a little richer. Kicking off in Yonglian Village, Zhangjiagang, this festival...

Continue Reading
CJ BIO's Bold Steps for Sustainable Animal Nutrition

Updated Category News Views 309

Breaking New Ground in Animal Nutrition Picture this: industry big wigs and farmers alike, all rubbing elbows at EuroTier 2026, the grand meeting ground for animal nutrition's future. This is where CJ BIO is flexing its muscles, not by just tossing ingredients into the mix, but by revolutionizing them under the banner "Feed Intelligence for Sustainable Performance." Now,...

Continue Reading
Afghanistan Claims Hong Kong Sixes in Thrilling Run Chase

Updated Category News Views 132

Afghanistan's Dazzling Triumph Brace ourselves, because what just unfolded in the Hong Kong Sixes 2026 is nothing short of spectacular. Afghanistan's cricket team penned a brand-new chapter in the game's history by overcoming Australia in a pulsating final to capture their maiden Hong Kong Sixes title. Imagine this: chasing a formidable target of 116, they wrapped up the...

Continue Reading
Perion Acquisition: Affle's Bold Leap in Ad Tech

Updated Category News Views 119

Affle's Strategic Acquisition of Perion Jumpin' through another hoop, Affle is gearing up to snag Perion in a hefty deal valued at about $420 million. For those of you not knee-deep in the ad tech sandbox, Affle—trading on the NSE as AFFLE—is aiming to ramp up its AI-driven conversion game by absorbing Perion, a veteran in the omnichannel advertising realm. "This...

Continue Reading
Isinwheel's 2027 E-Mobility Pitch: Beyond Resolutions

Updated Category News Views 117

Embracing the E-Mobility Shift Here we are at the tail end of 2026, and isinwheel is riding high on the wave of New Year resolutions with their hefty e-mobility lineup. It's not just about buying the gear—it's about tackling our reliance on gas-guzzlers with electric scooters and bikes as our trusty steeds. "Reduce car trips? More greenery in your commute? These aren't...

Continue Reading
TESSAN and Jamie Leibert's Daring Alpine Documentary Launch

Updated Category News Views 224

Steps Beyond the Obvious Adventure Launching headlong into the unknown—literally and figuratively—is what the documentary Jump Into The Unknown captures. TESSAN and Jamie Leibert have peeled back the curtain on adventure, showing us that it’s not just about the destination, but every twist, turn, and recalibrated step in between. The Backstory Behind Every Jump...

Continue Reading
Investcorp's Strong 2026: A Deep Dive into Key Moves

Updated Category News Views 18

Diving into Investcorp's Robust 2026 Performance If you're clued into the investment scene, you'll know that a $65.2 billion asset base isn't small potatoes. At the Gateway Gulf 2026, Investcorp didn't just present numbers—they laid out a dramatic year of action packed with billion-dollar dreams. While the dust hasn't quite settled yet, the first nine months of the year...

Continue Reading
UPM-Kymmene Finalizes Demerger: WISA Group to Nasdaq

Updated Category News Views 94

UPM-Kymmene Shakes Things Up Here's the meat and potatoes: UPM-Kymmene Corporation is going through a big change. They've decided to cut a part of themselves off and send it out into the world. This partial demerger has been registered, and now WISA Group Plc is stepping out from UPM's shadow. Where to? They're headed for the big league, getting listed on Nasdaq Helsinki....

Continue Reading

Top 5 Most Recently Viewed Articles

Intel's Transformation: A New Era as Strategic Infrastructure

Updated Category News Views 216

The Evolution of Intel's Stock Performance Recent movements in the stock price of Intel Corporation (NASDAQ: INTC) have illustrated a significant shift in the investment landscape. The company's shares crossed the $25 mark thanks to notable trading volume, signaling a transformative era for this tech giant. After a period of instability where the stock faced substantial...

Continue Reading
Polaris Triumphs Again with MacCachren Leading Baja 400 Race

Updated Category News Views 205

Polaris Shines at the Baja 400 Cayden MacCachren has done it again! At the recent fifth SCORE Baja 400, he showcased his impressive skills while leading the Polaris Factory Racing team. This race truly tested their abilities, and they managed to secure the top four positions in the UTV category. With this victory, MacCachren not only claimed first place but also moved...

Continue Reading
Immuneering Secures Major Funds Through Stock Offerings and Placement

Updated Category News Views 255

Immuneering Corporation's Major Stock Offerings Immuneering Corporation, a prominent player in the oncology sector, has made headlines with its latest financial strategies aimed at accelerating growth and product development. The company recently announced an underwritten public offering, priced at $9.23 per share, involving nearly 19 million shares of its Class A common...

Continue Reading
Future Growth of the Wound Care Market Forecasts Big Gains

Updated Category News Views 137

Wound Care Market Overview The global landscape for wound care products is witnessing a remarkable surge, driven by a sharp increase in cases of chronic and acute wounds. This rising demand creates compelling opportunities for manufacturers to innovate and expand their offerings. Consequently, conventional, bioactive, and various specialized wound care products are...

Continue Reading
Anticipating Meta's Earnings: AI Investments vs. Profit Strategies

Updated Category News Views 126

Meta's Upcoming Earnings: Insights and Expectations Meta Platforms (NASDAQ: META) is gearing up to announce its second-quarter earnings report. Investors are eager to see how the company's significant investments in artificial intelligence (AI) will balance with its profitability targets. Financial Expectations from the Earnings Report Analysts are optimistic about...

Continue Reading